Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 16.90B | 18.41B | 17.35B | 21.50B | 16.43B |
Gross Profit | 6.84B | 7.25B | 6.68B | 7.89B | 5.93B |
EBITDA | 3.36B | 3.64B | 3.20B | 3.58B | 2.95B |
Net Income | 2.06B | 2.30B | 1.91B | 2.25B | 1.92B |
Balance Sheet | |||||
Total Assets | 20.02B | 19.81B | 19.64B | 20.52B | 17.44B |
Cash, Cash Equivalents and Short-Term Investments | 4.08B | 3.52B | 4.08B | 3.22B | 3.67B |
Total Debt | 4.39B | 4.33B | 4.40B | 4.61B | 3.64B |
Total Liabilities | 6.37B | 6.73B | 7.11B | 7.77B | 6.03B |
Stockholders Equity | 12.71B | 12.08B | 11.56B | 11.71B | 10.74B |
Cash Flow | |||||
Free Cash Flow | 2.28B | 985.45M | 2.50B | 363.28M | 492.23M |
Operating Cash Flow | 3.32B | 2.55B | 4.06B | 2.32B | 1.92B |
Investing Cash Flow | -1.55B | -1.54B | -1.66B | -1.10B | -2.72B |
Financing Cash Flow | -1.50B | -1.28B | -1.33B | -844.19M | 1.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $2.22B | 8.27 | 16.66% | 4.37% | -7.82% | -9.64% | |
71 Outperform | $732.64M | 12.94 | 12.09% | 5.41% | -6.32% | -18.35% | |
70 Outperform | $1.55B | 16.23 | 9.84% | 2.31% | 3.04% | -16.49% | |
69 Neutral | $770.56M | 8.30 | 10.89% | ― | -7.47% | -9.07% | |
64 Neutral | £1.71B | 10.36 | 6.12% | 3.42% | 0.55% | -32.84% | |
63 Neutral | $1.33B | 46.81 | 2.28% | 3.77% | -2.68% | -56.16% | |
58 Neutral | $160.76M | 64.31 | 1.46% | 4.32% | -7.22% | ― |